ArticleHematological oncology2021
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Abstract readLetter
In one paragraph
Article in Hematological oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis.Revista da Associacao Medica Brasileira (1992) · 2024Pooled it
- Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies.European journal of haematology · 2026Review
- COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?Acta haematologica · 2024Review
- Management of infections for patient treated with ibrutinib in clinical practice.Frontiers in oncology · 2024Review
- Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.Clinical and experimental medicine · 2023Review
- COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.Biology · 2023Review
- Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.European journal of haematology · 2023Article
- COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report.Haematologica · 2022Article
- Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.Hematological oncology · 2022Article
- Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.Hematological oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
44 authors.
Antonio CuneoHematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0003-2001-1308
Gian Matteo RigolinHematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-8370-5190
Marta CosciaDivision of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Giulia QuaresminiUSC Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.
Lydia ScarfòUniversità Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy.
Francesca Romana MauroHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Marina MottaS.C. Ematologia, ASST Spedali Civili, Brescia, Italy.
Francesca Maria QuagliaDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy.
Livio TrentinHematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Italy.
Andrea FerrarioUOC Ematologia Azienda Socio Sanitaria Territoriale dei Sette Laghi, Ospedale di Circolo di Varese, Varese, Italy.
Luca LaurentiHematology, Fondazione Universitaria Policlinico A. Gemelli, Rome, Italy.ORCID https://orcid.org/0000-0002-8327-1396
Gianluigi RedaU.O.C. Ematologia, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
Angela FerrariHematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Daniela PietrasantaDivision of Hematology, SC di Ematologia, Ospedale Civile SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Paolo SportolettiDepartment of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S. Maria della Misericordia, Perugia, Italy.
Francesca ReHematology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Lorenzo De PaoliSCDU Ematologia AOU Maggiore della Carità, Novara, Italy.
Myriam FogliettaSC Ematologia Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
Annamaria GiordanoHematology-Department of Emergency and Organ Transplantation, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy.
Monia MarchettiHematology-Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, Italy.
Lucia FarinaFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Giovanni Del PoetaHematology, S. Eugenio Hospital, University of Tor Vergata, Rome, Italy.
Marzia VarettoniHematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Federico ChiurazziHematology Unit, University of Naples Federico II, Naples, Italy.
Roberto MarascaHematology Unit, University of Modena and Reggio Emilia, Modena, Italy.
Lara MalerbaUOC Ematologia e Centro trapianti AORMN Pesaro, Pesaro, Italy.
Adalberto IbaticiHematology and Bone Marrow Transplant, Policlinico San Martino, Genova, Italy.
Maria Chiara TisiHematology, Azienda ULSS 8 Berica Dipartimento Strutturale Oncologia Clinica Vicenza, Vicenza, Italy.
Vittorio StefoniDepartment of Hematology and Oncology "L. and A. Seràgnoli", Bologna, Italy.
Monica LeoneHematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
Claudia BaratèClinical and Experimental Medicine, Hematology Section, University of Pisa, Pisa, Italy.
Jacopo OlivieriHematology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
Roberta MurruSC Ematologia e CTMO Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy.
Massimo GentileUOC Ematologia AO Cosenza, Cosenza, Italy.
Alessandro SannaHemtology Unit, Azienda Ospedaliero Universitaria Careggi Firenze, Firenze, Italy.
Alessandro GozzettiHematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese Siena, Siena, Italy.ORCID https://orcid.org/0000-0003-0769-6891
Valter GatteiClinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Daniela GottardiSCDU Ematologia Ospedale Mauriziano, Torino, Italy.
Enrico DerenziniOncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Luciano LevatoSOC Ematologia, Dipartimento di Ematologia Oncologia Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Catanzaro, Italy.
Lorella OrsucciSC Ematologia, AUO Città della Scienza e della Salute di Torino, Torino, Italy.
Giuseppa PennaUOC Ematologia Policlinico Universitario di Messina, Messina, Italy.
Annalisa ChiarenzaDivisione di Ematologia con Trapianto di Midollo Osseo, Azienda Ospedaliera Universitaria Policlinico "G.Rodolico-S.Marco", Catania, Italy.
Robin FoàHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AgedCOVID-19Disease ManagementFemaleHumansItalyLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedPrognosisSARS-CoV-2Time FactorsVaccinationchronic lymphocytic leukemiaCOVID-19targeted agentsvaccination
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.